How where you live, what you eat, and which friends you keep affect how you age is the focus of a new study from The University of Texas at Arlington. Researchers are enrolling volunteers for the Arlington Study of Healthy Aging (ASHA), which will use advanced imaging, genetics, exercise science, neuroscience, and remote monitoring to investigate age-related health decline. The goal is to help individuals and health care practitioners better prevent the impact of disease on older adults.

The University of Texas at Arlington has once again earned the prestigious R1 designation from the Carnegie Classifications of Institutions of Higher Education, signifying the highest level of research activity. UTA is among just 187 institutions—4.7% nationwide—earning the R1 designation in 2025. First earning R1 status in 2015, UTA has maintained this classification through reaffirmations in 2018, 2021 and 2024, as part of Carnegie’s three-year review cycle. With research expenditures reaching $155 million in FY 2024—a 5% increase over FY23—UTA continues to demonstrate its commitment to innovation and academic excellence.

Findings could improve long-term outcomes for patients

An international research team led by the University of Zurich has published a review of more than 200 academic studies, revealing that success isn’t just about talent, hard work, or luck – it’s deeply shaped by hidden social forces. The study shows that our intuition about how these social forces shape success is often misleading, and it maps how recent research has challenged long-held assumptions. The collected findings have implications for policy, education, and careers. The authors explained that future efforts to better understand success could pave the way toward social systems where success better reflects quality, talent, and societal values – and where everyone has equal opportunities to flourish, regardless of their backgrounds.

University of Houston Huffington-Woestemeyer Professor of Chemical and Biomolecular Engineering Richard Willson - who turned glow-in-the-dark stars into ways to detect disease - has been elected as a fellow of the Royal Society of Chemistry. 

E. (Sarah) Du, Ph.D., an associate professor in College of Engineering and Computer Science at Florida Atlantic University, focuses her research on pioneering engineering solutions, developing single-cell assays and creating advanced in vitro disease models. These efforts span both basic research in cellular biomechanics and biophysics and applied biomedical applications, such as point-of-care diagnostic tools and monitoring systems for diseases such as sickle cell disease and malaria.